Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.5582/ddt.2020.01017 http://scihub22266oqcxt.onion/10.5582/ddt.2020.01017 32213760!ä!32213760 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Drug+Discov+Ther 2020 ; 14 (2): 105-106 Nephropedia Template TP {{tp|p=32213760|t=2020. Facts and reflections on COVID-19 and anti-hypertensives drugs |pdf=|usr=}}{{32213760}} gab.com Text Facts and reflections on COVID-19 and anti-hypertensives drugs JO: Drug Discov Ther http://www.kidney.de/pget.php?&tw=1&pmid=32213760 #FOAvip Based on some publications that associate SARS-CoV-2 infection with the use of anti-hypertensive drug groups such as angiotensin-converting-enzyme inhibitors (e.g. enalapril) or angiotensin II receptor blockers (e.g. losartan), many patients from South America, Central America or Spain, have stopped or intend to interrupt their treatments with these drugs. Hence, it may exist ominous consequences due to this drop out. For this reason, it is necessary to quickly warn about this situation and the risks associated with it. Twit Text FOAVip Facts and reflections on COVID-19 and anti-hypertensives drugs ????Drug Discov Ther http://www.kidney.de/pget.php?&tw=1&pmid=32213760 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32213760 #FOAvip English Wikipedia <ref>{{Cite pmid|32213760}}</ref> Facts and reflections on COVID-19 and anti-hypertensives drugs #MMPMID32213760 Marin GH Drug Discov Ther 2020[May]; 14 (2): 105-106 PMID32213760show ga Based on some publications that associate SARS-CoV-2 infection with the use of anti-hypertensive drug groups such as angiotensin-converting-enzyme inhibitors (e.g. enalapril) or angiotensin II receptor blockers (e.g. losartan), many patients from South America, Central America or Spain, have stopped or intend to interrupt their treatments with these drugs. Hence, it may exist ominous consequences due to this drop out. For this reason, it is necessary to quickly warn about this situation and the risks associated with it. |Angiotensin Receptor Antagonists/adverse effects[MESH] |Angiotensin-Converting Enzyme 2[MESH] |Angiotensin-Converting Enzyme Inhibitors/adverse effects[MESH] |Antihypertensive Agents/*adverse effects[MESH] |Betacoronavirus/physiology[MESH] |COVID-19[MESH] |Coronavirus Infections/*complications[MESH] |Enalapril/adverse effects[MESH] |Humans[MESH] |Hypertension/*complications/drug therapy[MESH] |Losartan/adverse effects[MESH] |Pandemics[MESH] |Peptidyl-Dipeptidase A[MESH] |Pneumonia, Viral/*complications[MESH] |SARS-CoV-2[MESH]Facts and reflections on COVID-19 and anti-hypertensives drugs (epmc).pdf DeepDyve Pubget Overpricing